Pages that link to "Item:Q3549405"
From MaRDI portal
The following pages link to Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates (Q3549405):
Displaying 11 items.
- Adaptive Bayesian compound designs for dose finding studies (Q434557) (← links)
- Bayesian models and decision algorithms for complex early phase clinical trials (Q903294) (← links)
- Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials (Q1654244) (← links)
- Individualized dosing for multiple ordered groups of patients (Q2320813) (← links)
- Optimizing the Concentration and Bolus of a Drug Delivered by Continuous Infusion (Q2893431) (← links)
- Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials (Q3576931) (← links)
- Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: With an Application to Treating Type 2 Diabetes Patients With Insulin Therapies (Q4690922) (← links)
- Patient-specific dose finding in phase I clinical trials (Q5036370) (← links)
- Patient-specific dose finding in seamless phase I/II clinical trials (Q5043686) (← links)
- Estimating individualized treatment rules with risk constraint (Q6047773) (← links)
- A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes (Q6076490) (← links)